Characterization of Vibrio Cholerae O1 Antigen As the Bacteriophage K139 Receptor and Identification of IS1004 Insertions Aborting O1 Antigen Biosynthesis

Overview

Journal J Bacteriol

Publisher American Society for Microbiology

Specialty Microbiology

Date 2000 Aug 26

PMID 10960093

Citations 30

Authors

J Nesper

D Kapfhammer

K E Klose

H Merkert

J Reidl

Affiliations

Soon will be listed here.

Abstract

Bacteriophage K139 was recently characterized as a temperate phage of O1 Vibrio cholerae. In this study we have determined the phage adsorption site on the bacterial cell surface. Phage-binding studies with purified lipopolysaccharide (LPS) of different O1 serotypes and biotypes revealed that the O1 antigen serves as the phage receptor. In addition, phage-resistant O1 El Tor strains were screened by using a virulent isolate of phage K139. Analysis of the LPS of such spontaneous phage-resistant mutants revealed that most of them synthesize incomplete LPS molecules, composed of either defective O1 antigen or core oligosaccharide. By applying phage-binding studies, it was possible to distinguish between receptor mutants and mutations which probably caused abortion of later steps of phage infection. Furthermore, we investigated the genetic nature of O1-negative strains by Southern hybridization with probes specific for the O antigen biosynthesis cluster (rfb region). Two of the investigated O1 antigen-negative mutants revealed insertions of element IS1004 into the rfb gene cluster. Treating one wbeW::IS1004 serum-sensitive mutant with normal human serum, we found that several survivors showed precise excision of IS1004, restoring O antigen biosynthesis and serum resistance. Investigation of clinical isolates by screening for phage resistance and performing LPS analysis of nonlysogenic strains led to the identification of a strain with decreased O1 antigen presentation. This strain had a significant reduction in its ability to colonize the mouse small intestine.

Citing Articles

Role of Bacteriophages in the Evolution of Pathogenic Vibrios and Lessons for Phage Therapy.

Molina-Quiroz R, Camilli A, Silva-Valenzuela C Adv Exp Med Biol. 2023; 1404:149-173.

PMID: 36792875 PMC: 10587905. DOI: 10.1007/978-3-031-22997-8_8.

Spontaneous Resistance of Against Bacteriophage Y2 Affects Infectivity of Multiple Phages.

Knecht L, Born Y, Pelludat C, Pothier J, Smits T, Loessner M Front Microbiol. 2022; 13:908346.

PMID: 35979490 PMC: 9376448. DOI: 10.3389/fmicb.2022.908346.

Interactions between the Prophage 919TP and Its Host: Implications of Mutation for Phage Resistance, Cell Auto-Aggregation, and Motility.

Li N, Zeng Y, Hu B, Zhu T, Svenningsen S, Middelboe M Viruses. 2021; 13(12).

PMID: 34960610 PMC: 8706939. DOI: 10.3390/v13122342.

Adaptive Synthesis of a Rough Lipopolysaccharide in Geobacter sulfurreducens for Metal Reduction and Detoxification.

Clark M, Paxhia M, Young J, Manzella M, Reguera G Appl Environ Microbiol. 2021; 87(20):e0096421.

PMID: 34347518 PMC: 8478458. DOI: 10.1128/AEM.00964-21.

Broadscale phage therapy is unlikely to select for widespread evolution of bacterial resistance to virus infection.

Cohan F, Zandi M, Turner P Virus Evol. 2020; 6(2):veaa060.

PMID: 33365149 PMC: 7744382. DOI: 10.1093/ve/veaa060.

References

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Levine M, Ristaino P, Marley G, Smyth C, Knutton S, Boedeker E . Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun. 1984; 44(2):409-20. PMC: 263534. DOI: 10.1128/iai.44.2.409-420.1984. View

Waldor M, Colwell R, Mekalanos J . The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc Natl Acad Sci U S A. 1994; 91(24):11388-92. PMC: 45236. DOI: 10.1073/pnas.91.24.11388. View

Kenne L, Lindberg B, Unger P, Gustafsson B, Holme T . Structural studies of the Vibrio cholerae O-antigen. Carbohydr Res. 1982; 100:341-9. DOI: 10.1016/s0008-6215(00)81047-2. View

Pearson G, Woods A, Chiang S, Mekalanos J . CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc Natl Acad Sci U S A. 1993; 90(8):3750-4. PMC: 46379. DOI: 10.1073/pnas.90.8.3750. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

Ito T, Higuchi T, Hirobe M, Hiramatsu K, Yokota T . Identification of a novel sugar, 4-amino-4,6-dideoxy-2-O-methylmannose in the lipopolysaccharide of Vibrio cholerae O1 serotype Ogawa. Carbohydr Res. 1994; 256(1):113-28. DOI: 10.1016/0008-6215(94)84231-0. View

Ward H, Manning P . Mapping of chromosomal loci associated with lipopolysaccharide synthesis and serotype specificity in Vibrio cholerae 01 by transposon mutagenesis using Tn5 and Tn2680. Mol Gen Genet. 1989; 218(2):367-70. DOI: 10.1007/BF00331294. View

Hall R, Khambaty F, Kothary M, Keasler S . Non-O1 Vibrio cholerae. Lancet. 1993; 342(8868):430. DOI: 10.1016/0140-6736(93)92839-l. View

10.

Hisatsune K, Kondo S, Isshiki Y, Iguchi T, Haishima Y . Occurrence of 2-O-methyl-N-(3-deoxy-L-glycero-tetronyl)-D-perosamine (4-amino-4,6-dideoxy-D-manno-pyranose) in lipopolysaccharide from Ogawa but not from Inaba O forms of O1 Vibrio cholerae. Biochem Biophys Res Commun. 1993; 190(1):302-7. DOI: 10.1006/bbrc.1993.1046. View

11.

Mekalanos J . Duplication and amplification of toxin genes in Vibrio cholerae. Cell. 1983; 35(1):253-63. DOI: 10.1016/0092-8674(83)90228-3. View

12.

Iredell J, Stroeher U, Ward H, Manning P . Lipopolysaccharide O-antigen expression and the effect of its absence on virulence in rfb mutants of Vibrio cholerae O1. FEMS Immunol Med Microbiol. 1998; 20(1):45-54. DOI: 10.1111/j.1574-695X.1998.tb01110.x. View

13.

Stroeher U, Parasivam G, Dredge B, Manning P . Novel Vibrio cholerae O139 genes involved in lipopolysaccharide biosynthesis. J Bacteriol. 1997; 179(8):2740-7. PMC: 179025. DOI: 10.1128/jb.179.8.2740-2747.1997. View

14.

Stroeher U, Jedani K, Manning P . Genetic organization of the regions associated with surface polysaccharide synthesis in Vibrio cholerae O1, O139 and Vibrio anguillarum O1 and O2: a review. Gene. 1998; 223(1-2):269-82. DOI: 10.1016/s0378-1119(98)00407-7. View

15.

Baselski V, Parker C . Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells. Infect Immun. 1978; 21(2):518-25. PMC: 422026. DOI: 10.1128/iai.21.2.518-525.1978. View

16.

Bik E, Bunschoten A, Gouw R, Mooi F . Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J. 1995; 14(2):209-16. PMC: 398072. DOI: 10.1002/j.1460-2075.1995.tb06993.x. View

17.

REDMOND J . The structure of the O-antigenic side chain of the lipopolysaccharide of Vibrio cholerae 569B (Inaba). Biochim Biophys Acta. 1979; 584(2):346-52. DOI: 10.1016/0304-4165(79)90280-0. View

18.

Bik E, Gouw R, Mooi F . DNA fingerprinting of Vibrio cholerae strains with a novel insertion sequence element: a tool to identify epidemic strains. J Clin Microbiol. 1996; 34(6):1453-61. PMC: 229041. DOI: 10.1128/jcm.34.6.1453-1461.1996. View

19.

Rose R . The nucleotide sequence of pACYC177. Nucleic Acids Res. 1988; 16(1):356. PMC: 334640. DOI: 10.1093/nar/16.1.356. View

20.

Fallarino A, Mavrangelos C, Stroeher U, Manning P . Identification of additional genes required for O-antigen biosynthesis in Vibrio cholerae O1. J Bacteriol. 1997; 179(7):2147-53. PMC: 178949. DOI: 10.1128/jb.179.7.2147-2153.1997. View